August 18, 2008 - ETEX Corp. launched EquivaBone, a bone graft substitute that remodels and is replaced with new bone during the healing process.
EquivaBone is a proprietary combination of osteoinductive Demineralized Bone Matrix (DBM) and ETEX’s osteoconductive nanocrystalline calcium phosphate. ETEX now offers reportedly the first combination product that is both moldable and injectable and sets hard once implanted. In addition, osteoinductivity of the DBM is certified after sterilization, by lot, for the entirety of shelf life.
Both trauma and spine fusion data were included in the 510k submission which received FDA clearance on April 28, 2008. EquivaBone is intended for use in filling bone voids or defects of the skeletal system (including extremities, pelvis, and spine) that are not intrinsic to the stability of the bone structure.
For more information: www.etexcorp.com